Real-time elastography with a novel quantitative technology for assessment of liver fibrosis in chronic hepatitis B

Background

The accurate evaluation of liver fibrosis stage is important in determining the treatment strategy. The limitations of percutaneous liver biopsy as the gold standard are obvious for invasion. Real-time elastography with conventional ultrasound probes and a new quantitative technology for diffuse histological lesion is a novel approach for staging of liver fibrosis.

Purpose

This study aimed to evaluate the value of real-time tissue elastography with a new quantitative technology for the assessment of liver fibrosis stage.

Materials and methods

Real-time elastography was performed in 55 patients with liver fibrosis and chronic hepatitis B and in 20 healthy volunteers. Eleven parameters for every patient in colorcode image obtained from the real-time elastography were analyzed with principal components analysis. We analyzed the correlation between elasticity index and liver fibrosis stage and the accuracy of real-time elastography for liver fibrosis staging. Additionally, aspartate transaminase-to-platelet ratio index was also included in the analysis.

Results

The Spearman's correlation coefficient between the elasticity index and the histologic fibrosis stage was 0.81, which is highly significant (p < 0.001). The areas under receiver operating characteristic curves indicating diagnostic accuracy were 0.93 (F ≥ F1, p < 0.001) for the diagnosis of liver fibrosis, 0.92 (F ≥ F2, p < 0.001), 0.84 (F ≥ F3, p < 0.05) and 0.66 (F = F4, p > 0.05), respectively.

Conclusions

Real-time elastography with a new quantitative technology for diffuse histological lesion is a new and promising sonography-based noninvasive method for the assessment of liver fibrosis in patients with chronic hepatitis B.     

Diffusion weighted MRI and transient elastography assessment of liver fibrosis in hepatitis C patients: Validity of non invasive imaging techniques

Objective

Treatment for hepatitis C infection and monitoring of progression were based on degree of fibrosis, which were traditionally diagnosed by liver biopsy but it has many limitations. We aim to evaluate noninvasive imaging methods, so-called diffusion-weighted MRI (DW MRI) and transient elastography [(TE), fibroscan] in diagnosing liver fibrosis in hepatitis C (HCV) patients.

Patients

The Study included 102 hepatitis C patients (62 male) with mean age of 38 ± 5. For all patients liver biopsy was done followed by DW MRI and TE. METAVIR classification system was used for staging liver fibrosis. Data obtained were collected and results of DW MRI and TE were compared with those of histopathology. The diagnostic performance of ADC and TE was determined using areas under receiver operating characteristic (AUROC) curves for significant fibrosis ?F3.

Results

Measuring ADC at different b-values had a significant negative correlation with stage of fibrosis P = 0.001, the best negative correlation at b-value of 700 mm²/s. TE had a significant positive correlation with stage of fibrosis P = 0.005. Both examination showed a significant difference between fibrosis stage <F3 and stages ?F3 with P < 0.00 for ADC measure at each b-value and TE respectively.

Conclusion

This study suggests that DW MRI and TE had favorable comparable results with liver biopsy for the diagnosis of significant liver fibrosis.     

A preliminary study of apparent diffusion coefficient in chemotherapy-induced liver damage

Objectives

To investigate changes in the hepatic apparent diffusion coefficient (ADC) in patients undergoing chemotherapy.

Methods

We enrolled 54 patients (25 women; mean age 57.0 ± 13.1 years, range 29–89 years) undergoing chemotherapy for tumor and 10 controls (7 women; mean age 55.1 ± 17.5 years, range 23–81 years). The patients were tested for serum alanine aminotransferase (ALT) activity (abnormal, normal) and fatty liver. Hepatic ADC values were compared among controls, patients and subgroups. Pearson correlation coefficient was used to assess the correlation between ADC and ALT activity.

Results

Hepatic ADC0,850 (×10⁻³ mm²/s) was lower for patients than controls (1.14 ± 0.18 vs. 1.28 ± 0.12, P = 0.02) and was lower for patients with than without fatty liver and controls (1.01 ± 0.06 vs. 1.18 ± 0.18 and 1.28 ± 0.12, respectively, all P < 0.01), with no significant difference between patients without fatty liver and controls (P = 0.07). ADC0,850 was lower for patients with abnormal ALT than normal ALT activity and controls (0.99 ± 0.06 vs. 1.17 ± 0.18 and 1.28 ± 0.12, respectively, all P < 0.05), with a significant difference also being seen between patients with normal ALT activity and controls (P = 0.04). Hepatic ADC0,850 was not correlated with ALT activity in patients (r = -0.24, P = 0.08).

Conclusions

Although ADC did not correlate with ALT values, it did distinguish patient likely to have chemotherapy-induced liver damage as indicated by abnormal ALT values or fatty liver. These mechanisms need to be disentangled.     

Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration

Purpose

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) enhanced liver MRI is widely used for detection and differentiation of focal liver lesions. Diffusion weighted imaging (DWI) including apparent diffusion coefficient (ADC) measurements is increasingly utilised as a fast and, with limitations, quantitative method for liver lesion detection and characterisation. Herein we investigate whether the administration of Gd-EOB-DTPA affects DWI.

Materials and methods

31 consecutive patients referred to standardised liver MRI (1.5 T, Gd-EOB-DTPA, 0.025 mmol/kg) were retrospectively reviewed. All underwent a breathhold DWI sequence before and after contrast agent administration (EPI-DWI, TR/TE (effective): 2100/62 ms, b-values: 0 and 800 s/mm²). Patients with previously treated liver lesions were excluded. Signal intensity of lesion, parenchyma and noise on DWI images as well as the ADC value were measured after identification by two observers in consensus using manually placed regions of interest. The reference standard was imaging follow-up determined separately by two radiologists. Data analysis included signal-to-noise (SNR) ratio and contrast-to-noise ratio (CNR) calculations, comparisons were drawn by employing multiple Bonferroni corrected Wilcoxon signed-rank tests.

Results

50 malignant and 39 benign lesions were identified. Neither SNR, CNR nor ADC values showed significant differences between pre- and postcontrast DWI. Both pre- and postcontrast ADC values differed significantly between benign and malignant lesions (P < 0.001).

Conclusion

We did not identify a significant influence of Gd-EOB-DTPA on DWI of liver lesions. This allows for individual tailoring of imaging protocols according to clinical needs.     

Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness

Objective

To evaluate the relationship between apparent diffusion coefficient (ADC) value and the local invasiveness of endometrial carcinoma.

Methods and materials

The MR imaging of seventy-three patients with endometrial carcinoma proved by post-operative pathology and sixty-four patients with healthy uteri were retrospectively reviewed. All MR examinations included axial T2WI and T1WI, sagittal T2WI and diffusion-weighted sequences (b = 0 and b = 1000 s/mm²). Tumor size, mean ADC value (ADCm) and quartile ADC (ADCq) were acquired on post-processing workstation using voxel-analysis software. Differences between the ADC values among three layers of normal uterine body and endometrial carcinomas were compared by ANOVA test. Groups were divided according to pathologic type, histologic grade, depth of myometrial infiltration, presence of cervical invasion and lymphovascular space invasion, and lymph node metastasis. Tumor size and ADC values were compared and analyzed.

Results

ADC values were different in three zones of uterine body (P < 0.001), with the lowest in junctional zone [(1.126 ± 0.190) × 10⁻³ mm²/s] and highest in outer myometrium [(1.496 ± 0.196) × 10⁻³ mm²/s]. Mean ADC value of endometrial carcinomas [(1.011 ± 0.121) × 10⁻³ mm²/s] was lower than the normal uterine body. Quartile ADC and tumor size were greater in groups with more invasive pathologic factors (P < 0.05). Deep myometrial infiltration, cervical invasion, lymphovascular space invasion and lymph node metastasis were more common as quartile ADC values and tumor sizes increased.

Conclusion

Mean ADC value was lower in endometrial carcinoma was lower than the normal uterus. Quartile ADC, representing the intra-tumor heterogeneity of water movement, had a profound relationship with invasiveness of endometrial carcinomas, while mean ADC value did not. ADC values may serve as a quantitative indicator to complement routine sequences.     

Is diffusion-weighted imaging useful in grading and differentiating histopathological subtypes of meningiomas?

Purpose

Meningiomas are mostly benign, however atypical or malignant subtypes with more aggressive clinical course and higher recurrence rates can also be seen. The purpose of this study was to determine whether histopathological subtypes of meningiomas could be assessed preoperatively using apparent diffusion coefficient (ADC) values.

Materials and methods

Conventional magnetic resonance (MR) and diffusion-weighted (DW) imaging of 177 adult patients with pathologically proven meningiomas were retrospectively evaluated. Tumor size and the degree of associated edema were noted. The signal intensity of the lesions on DW imaging was evaluated and graded. Mean ADC values were obtained as the mean of measurements from three regions of interests within the mass. ADC ratios of meningioma/contralateral normal appearing subcortical parietal white matter were also calculated.

Results

The histopathological analysis revealed 135 benign, 37 atypical and 5 malignant lesions. With classification according to the subtype, the mean ADC values and ratios of benign meningiomas were as 0.99 ± 0.12 × 10⁻³ mm²/s and 1.22 ± 0.07, respectively. ADC values for atypical and malignant groups were both 0.84 ± 0.1 × 10⁻³ mm²/s. The ADC ratios were 1.05 ± 0.1 and 0.96 ± 0.2 for atypical and malignant subtypes, respectively. There was no statistically significant difference between the mean ADC ratios of the three subtypes (ANOVA test; P ≥ 0.05). Gender, age of the patients and tumor size showed no statistically significant difference between the different histological groups.

Conclusion

DW MR imaging was not found to have any additional value in determining histological behaviour nor in differentiating histopathological subtypes of meningiomas.     

Apparent diffusion coefficient values of mediastinal masses in children

Objective

Compare apparent diffusion coefficient (ADC) values between benign and malignant mass lesions in a cohort of children referred for imaging of a mediastinal mass.

Material and methods

Prospective study including 24 consecutive children (11 boys, 13 girls aged 5 months to 16 years). All underwent echo planar diffusion weighted MR imaging of the mediastinum with b-factors of 0 and 600 s/mm². Apparent diffusion coefficient (ADC) values were calculated and correlated with the surgical finding or biopsy.

Results

The mean ADC value of malignant mediastinal tumors was 0.91 (S.D., 0.17) ×10⁻³ mm²/s and of benign lesions 1.8 (S.D., 0.33) ×10⁻³ mm²/s. There was significant different in the ADC value between malignant tumors and benign mediastinal tumors (P < 0.001). Selection of 1.2 × 10⁻³ mm²/s as a threshold value for differentiating malignant from benign mediastinal masses has an accuracy of 93%, sensitivity of 92%, specificity of 94%, positive predictive value of 94%, negative predictive value of 92% and area under the curve of 0.962.

Conclusion

Apparent diffusion coefficient value is a promising non-invasive parameter for assessment of mediastinal mass in children.     

Tissue characterization of head and neck lesions using diffusion-weighted MR imaging with SPLICE

Purpose

The purpose of this study was to evaluate the usefulness of diffusion-weighted (DW) MR imaging with split acquisition of fast spin-echo signals (SPLICE) in the tissue characterization of head and neck mass lesions.

Patients and methods

DW MR images of 67 head and neck mass lesions were obtained using SPLICE with b-factors of 0 and 771 s/mm². The lesions were classified into three categories: 16 cysts, 32 benign tumors, and 19 malignant tumors. After ADC maps were constructed for all lesions, ADC values were calculated and compared among the three categories.

Results

No case showed severe image distortion on DW MR imaging with SPLICE, and reliable ADC maps and ADC values were obtained in all cases. The mean ADC value of cysts was 2.41 ± 0.48 × 10⁻³ mm²/s, which was significantly higher than that of benign (1.48 ± 0.62 × 10⁻³ mm²/s) and malignant (1.23 ± 0.45 × 10⁻³ mm²/s) tumors (P < 0.001). However, there was no significant difference between the ADC values of benign and malignant tumors (P = 0.246). When an ADC value of 2.10 × 10⁻³ mm²/s or higher was used as the diagnostic criterion for cysts, the sensitivity, specificity, and accuracy were 94%, 88%, and 90%, respectively.

Conclusion

SPLICE was considered a recommended DW MR imaging technique for the head and neck. Although ADC values were useful in differentiating cysts from tumors, they contributed little in predicting malignancy.     

Utility of chemical shift and diffusion-weighted imaging in characterization of hyperattenuating adrenal lesions at 3.0T

Objective

The purpose of our study was to evaluate the value of chemical shift imaging (CSI) and diffusion weighted imaging (DWI) at 3.0 T MRI in adrenal hyperattenuating lesions.

Methods

Fifty-one hyperattenuating adrenal lesions in 40 patients were evaluated. Signal intensity index (SII), adrenal to spleen ratio (ASR) and apparent diffusion coefficient (ADC) were used as quantitative analysis parameters.

Results

The mean SII, ASR and ADC values were: benign pheochromocytomas (n = 22), 7.04%; 0.96, 1.15 × 10⁻³ mm²/s; lipid-poor adenomas (n = 18), 33.77%, 0.71, 1.07 × 10⁻³ mm²/s; malignant tumors (n = 7), 11.24%; 1.00; 0.92 × 10⁻³mm²/s. There were significant differences between the lipid-poor adenomas and nonadenomas for SII and ASR, and there were significant differences between the benign and the malignant tumor ADC values. The optimal diagnostic threshold point of SII and ASR for lipid-poor adenomas was 11.96%, 0.83, the sensitivity and specificity were 88.9%, 97.5% and 97%, 83.3%. The optimal diagnostic threshold point of ADC value for benign lesions and malignant tumors was 1.04 × 10⁻³ mm²/s, the sensitivity and specificity were 61.4% and 85.7%.

Conclusion

Quantitative analysis of chemical shift MRI and DWI can help to characterize the hyperattenuating adrenal lesions, especially in differentiatiation between the lipid-poor adenomas, the benign pheochromocytomas, and the malignant tumors.     

Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma

Objectives

To measure the sensitivity of diffusion-weighted imaging (DWI) and determine the most appropriate b value for DWI; to explore the correlation between the apparent diffusion coefficient (ADC) value and the degree of extrahepatic cholangiocarcinoma differentiation.

Methods

Preoperative diffusion-weighted imaging and magnetic resonance examinations were performed for 31 patients with extrahepatic cholangiocarcinoma. Tumor ADC values were measured, and the signal-to-noise ratio, contrast-to-noise ratio, and signal-intensity ratio between the diffusion-weighted images with various b values as well as the T2-weighted images were calculated. Pathologically confirmed patients were pathologically graded to compare the ADC value with different b values of tumor at different degrees of differentiation, and the results were statistically analyzed by using the Friedman test.

Results

A total of 29 cases of extrahepatic cholangiocarcinoma were detected by DWI. As the b value increased, tumor signal-to-noise ratio and contrast-to-noise ratio between the tumor and normal liver gradually decreased, but the tumor signal-intensity ratio gradually increased. When b = 800 s/mm², contrast-to-noise ratio between tumor and normal liver, tumor signal-intensity ratio, and tumor signal-to-noise ratio of diffusion-weighted images were all higher than those of T2-weighted images; the differences were statistically significant (P < 0.05). As the b value increased, the tumor ADC value gradually declined. As the degree of differentiation decreased, the tumor ADC value declined.

Conclusion

The b value of 800 s/mm² was the best in DWI of extrahepatic cholangiocarcinoma; the lesion ADC value declined as the degree of cancerous tissue differentiation decreased.     

Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI

Purpose

To test the feasibility of apparent diffusion coefficient (ADC) value obtained with 3.0 T diffusion-weighted imaging (DWI) in the characterization of renal cell carcinomas (RCC) with different pathological subtypes and grades.

Materials and methods

A total of 137 patients who were diagnosed with RCC and underwent DWI were included in this study. The diagnosis was confirmed by pathological examination of surgical specimens. Images of DWI were obtained with b values of 0 and 800 s/mm². The ADC values in the solid area of tumors and in the corresponding regions of contralateral normal renal parenchyma were measured and analyzed statistically.

Results

The mean ADC value was significantly lower in RCC (1.381 ± 0.444 × 10⁻³ mm²/s) than in normal renal parenchyma (2.232 ± 0.221 × 10⁻³ mm²/s) (P < 0.001). The ADC value was also statistically different between clear cell RCC (CCRCC) and non-CCRCC, and between different grades of CCRCC except grade I vs II and grade III vs IV.

Conclusion

ADC measurement on 3.0 T DWI provides useful information in diagnostic work-up of RCC in terms of differentiation of RCC and normal renal parenchyma, and characterization of RCC with different pathological subtypes and grades.     

Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation

Objective

To evaluate the diagnostic accuracy of liver apparent diffusion coefficient (ADC) measured with conventional diffusion-weighted imaging (CDI) and diffusion tensor imaging (DTI) for the diagnosis of liver fibrosis and inflammation.

Materials and methods

Thirty-seven patients with histologic diagnosis of chronic viral hepatitis and 34 healthy volunteers were included in this prospective study. All patients and healthy volunteers were examined by 3 T MRI. CDI and DTI were performed using a breath-hold single-shot echo-planar spin echo sequence with b factors of 0 and 1000 s/mm². ADCs were obtained with CDI and DTI. Histopathologically, fibrosis of the liver parenchyma was classified with the use of a 5-point scale (0–4) and inflammation was classified with use of a 4-point scale (0–3) in accordance with the METAVIR score. Quantitatively, signal intensity and the ADCs of the liver parenchyma were compared between patients stratified by fibrosis stage and inflammation grade.

Results

With a b factor of 1000 s/mm², the signal intensity of the cirrhotic livers was significantly higher than those of the normal volunteers. In addition, ADCs reconstructed from CDI and DTI of the patients were significantly lower than those of the normal volunteers. Liver ADC values inversely correlated with fibrosis and inflammation but there was only statistically significant for inflammatory grading. CDI performed better than DTI for the diagnosis of fibrosis and inflammation.

Conclusion

ADC values measured with CDI and DTI may help in the detection of liver fibrosis. They may also give contributory to the inflammatory grading, particularly in distinguishing high from low grade.     

Evaluation of MR diffusion-weighted imaging in differentiating endometriosis infiltrating the bowel from colorectal carcinoma

Objective

Endometriosis infiltrating the bowel may be difficult to differentiate from colorectal carcinoma in cases that present with non-specific clinical and imaging features. The aim of this study is to assess the value of MR diffusion-weighted imaging (DWI) in differentiating endometriosis infiltrating the bowel from colorectal carcinoma.

Methods

In 66 patients, MR DWI was added to the standard imaging protocol in patients visiting our outdoor MR clinic for the analysis of suspected or known deep infiltrating endometriosis (DIE). In patients diagnosed with DIE infiltrating the bowel on MR imaging, high b-value diffusion-weighted images were qualitatively assessed by two readers in consensus and compared to high b-value diffusion weighted images in 15 patients evaluated for colorectal carcinoma. In addition, ADC values of lesions were calculated, using b-values of 50, 400 and 800 s/mm².

Results

A total of 15 patients were diagnosed with DIE infiltrating the bowel on MR imaging. Endometriosis infiltrating the bowel showed low signal intensity on high b-value diffusion-weighted images in all patients, whereas colorectal carcinoma showed high signal intensity on high b-value diffusion-weighted images in all patients. Mean ADC value in endometriosis infiltrating the bowel (0.80 ± 0.06 × 10⁻³ mm²/s) was significantly lower compared to mean ADC value in colorectal carcinoma (0.86 ± 0.06 × 10⁻³ mm²/s), but with considerable overlap between ADC values.

Conclusion

Only qualitative assessment of MR DWI may be valuable to facilitate differentiation between endometriosis infiltrating the bowel and colorectal carcinoma.     

The role of ADC measurement in differential diagnosis of focal hepatic lesions

Purpose

To evaluate the utility of apparent diffusion coefficient (ADC) measurement in characterization of focal solid hepatic lesions and determine the role of ADC values in differentiation of solid benign and solid malignant hepatic lesions.

Materials and methods

Between June 2006 and December 2010, a total of 95 focal solid hepatic lesions in 95 consecutive patients were evaluated by abdominal MRI. Diffusion weighted MRI was performed with b 100, b 600 and b 1000 gradients with ADC measurements. Comparison of mean ADC values between solid benign (focal nodular hyperplasia and other solid benign lesions) and solid malignant lesion (hepatocellular carcinoma, metastasis, and cholangiocarcinoma) groups and between each benign and malignant lesion was done. The ROC analyses were performed in order to determine cut-off ADC values for differentiation of benign and malignant lesion groups at 3 different gradients.

Results

Twenty-six of 95 lesions were benign and 69 were malignant. Mean ADC values of solid benign lesions at b 100, b 600 and b 1000 gradients were 2.25 ± 0.54 × 10⁻³, 1.97 ± 0.64 × 10⁻³ and 1.52 ± 0.47 × 10⁻³ mm²/s, respectively. Mean ADC values of solid malignant lesions at b 100, b 600 and b 1000 gradients were 1.84 ± 0.57 × 10⁻³, 1.37 ± 0.38 × 10⁻³ and 1.08 ± 0.22 × 10⁻³ mm²/s, respectively. The ADC values of solid benign lesions were significantly higher than solid malignant lesions at all 3 gradients (P < 0.05). Differentiation of benign and malignant subtype lesions from each other in their groups did not yield as significant findings as comparing results between benign and malignant lesions.

Conclusion

Although ADC measurements were not helpful for differentiating subtypes of solid benign or solid malignant lesions, ADC measurements at 3 different gradients may be useful in differential diagnosis of benign lesions from malignant ones.     

Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization

Objectives

to evaluate the prognostic value of apparent diffusion coefficient (ADC) values from MR diffusion-weighted imaging of unresectable hepatocellular carcinoma after chemoembolization.

Methods

our study was proved by our institute and informed consent was obtained from all patients before commencement of the study. Twenty-three patients with unresectable hepatocellular carcinoma were scanned immediately before and after chemoembolization within 24 h using conventional anatomical MR imaging and diffusion-weighted imaging, from which ADC values in the lesions were measured. The changes in ADC values after chemoembolization were calculated. The relationship between the lesion ADC and the survival time was analyzed by correlation analysis. The overall cumulative survival was analyzed by the Kaplan–Meier method, and survival curves were compared by the log-rank test.

Results

the mean overall survival period was (25.0 ± 8.7) months. The pre-chemoembolization lesion ADC value was (1.36 ± 0.249) ×10⁻³ mm²/s; the change in ADC values post-chemoembolization was (0.377 ± 0.332) ×10⁻³ mm²/s. There were significant linear regression relation between the survival time and pre-chemoembolization lesion ADC values (r = −0.698, P < 0.001) or the changes in ADC value post-chemoembolization (r = 0.702, P < 0.001). And Log-rank test showed that pre-chemoembolization ADC values (χ² = 7.339, P = 0.007) or the changes in ADC value post-chemoembolization (χ² = 9.820, P = 0.002) significantly influenced the overall cumulative survival.

Conclusion

Pre-treatment ADC values as well as changes in ADC values after treatment may provide useful information for predicting survival for patients with unresectable hepatocellular carcinoma.     

Apparent diffusion coefficient values of the normal uterus: Interindividual variations during menstrual cycle

Objectives

To assess the apparent diffusion coefficient (ADC) changes of the normal uterine zones among reproductive women during the menstrual cycle.

Methods

The study included 101 women of reproductive age, each with regular cycle and normal endometrium/myometrium, as proved on histopathology or MR imaging examination. Diffusion-weighted (DW) imaging was performed along the axial plane, using a single shot, multi-slice spin-echo planar diffusion pulse sequence and b-values of 0 and 800 s/mm². The mean and standard deviation of the ADC values of normal endometrium/myometrium were calculated for menstrual, proliferative and secretory phase. Analysis of variance followed by the least significant difference test was used for statistical analysis.

Results

The ADC values of the endometrium were different in the three phases of the menstrual cycle (menstrual phase: 1.25 ± 0.27; proliferative phase: 1.39 ± 0.20; secretory phase: 1.50 ± 0.18) (F: 9.64, p: 0.00). Statistical significant difference was observed among all groups (p < 0.05). The ADC values of the normal myometrium were different in the three phases of the menstrual cycle (menstrual phase: 1.91 ± 0.35; proliferative phase: 1.72 ± 0.27; secretory phase: 1.87 ± 0.28) (F: 3.60, p: 0.03). Statistical significant difference was observed between menstrual and proliferative phase and between proliferative and secretory phase (p < 0.05). No significant difference was noted between menstrual and secretory phase (p > 0.05).

Conclusions

A wide variation of ADC values of normal endometrium and myometrium is observed during different phases of the menstrual cycle.     

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD

Background

Transient elastography (TE) and acoustic radiation force impulse (ARFI)-imaging have shown promising results for the staging of liver fibrosis.

Aim

The aim of the present study was to compare ARFI of the left and right liver lobe with TE using the standard and obese probes for the diagnosis of liver fibrosis in NAFL/NASH. In addition, liver steatosis is evaluated using the novel controlled attenuation parameter (CAP).

Methods

Sixty-one patients with NAFLD/NASH were included in the study. All patients received TE with both probes, ARFI of both liver lobes and CAP. The results were compared with liver histology.

Results

57 patients were included in the final analysis. The diagnostic accuracy for TE measurements with the M-and XL-probe and for ARFI of the right and left liver lobe was 0.73, 0.84, 0.71 and 0.60 for the diagnosis of severe fibrosis, and 0.93, 0.93, 0.74 and 0.90 for the diagnosis of cirrhosis, respectively. No significant difference of results was observed between TE and ARFI in the subgroup of patients with reliable TE-measurement when taking into account the best results of both methods. However, while a significant correlation could be found for TE with histological liver fibrosis, the correlation of ARFI with liver fibrosis was not statistically significant. A significant correlation was found for CAP with histological steatosis (r = 0.49, p < 0.001).

Conclusions

No significant difference in diagnostic accuracy for the non-invasive assessment of liver fibrosis was found for transient elastography and ARFI. Nevertheless TE significantly correlated with liver fibrosis while ARFI did not. CAP enables the non-invasive assessment of steatosis.     

Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification

Purpose

Our purpose was to determine whether quantitative diffusion-weighted MR imaging (DWI) could be used in discrimination of benign and malignant primary solid and cystic renal tumors.

Materials and methods

A total of 105 consecutive patients with renal masses and 30 healthy controls were enrolled in this prospective study. Dynamic contrast enhanced routin renal images and DWI (with b factors of 0, 500 and 1000 s/mm²) was performed at 1.5 T unit. Renal masses were divided into two groups as cystic or solid and all cystic lesions were prospectively assigned to a Bosniak classification number. The median apparent diffusion coefficient (ADC) values along with b 500 and 1000 signal intensities of normal kidneys, solid components of mixed renal masses and total of cystic lesions were calculated.

Results

The mean ADC value of normal renal parenchyma in control group was 2.18 ± 0.13 × 10⁻³ mm²/s. Solid renal tumors had significant lower ADC values (median: 1.16 ± 0.27 × 10⁻³ mm²/s), in contrast to cystic tumors (median: 2.73 ± 0.44 × 10⁻³ mm²/s). The mean ADC value of the Bosniak Category I cysts was significantly higher (3.09 ± 0.14 × 10⁻³ mm²/s) than normal renal parenchyma (p < 0.01). A statistical significance was achieved between the signal intensity of Bosniak Category I and Category II–III cysts with b 1000 (p < 0.05). Among the different histologic subtypes of renal cell carcinoma, the mean ADC value of chromophobe cell carcinoma (1.41 ± 0.09 × 10⁻³ mm²/s) was significantly higher than that of papillary cell carcinoma (0.90 ± 0.16 × 10⁻³ mm²/s) and clear cell carcinoma (1.23 ± 0.13 × 10⁻³ mm²/s).

Conclusion

Accurate assessment of renal masses is important for establishing whether tumors require surgical intervention or not. While MRI is a useful modality as an investigative tool for diagnosing, characterizing and staging renal masses, DWI contributes additional value by promising differentiation benign from malignant renal tumors, even histologically subtyping of renal cell cancer.     

Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: Is it still reliable?

Purpose

Diffusion weighted imaging (DWI) is an emerging technique for abdominal MR and usually performed before intravenous contrast injection. Recent studies performed in patients with normal liver function have shown that DWI can be performed after gadolinium administration. Aim of this study was to compare DWI before and after administration of different gadolinium compounds in patients with HCC and liver cirrhosis.

Materials and methods

15 patients with known HCC and liver cirrhosis underwent liver MRI at 1.5 T (Magnetom Avanto, Siemens) including DWI on day 1 before and after administration of gadobutrol (Gadovist^®) and on day 2 after administration of EOB-Gadolinium-DTPA (Primovist^®). Signal to noise ratios (SNR) and contrast to noise ratios (CNR) of HCC lesions were determined for all DWI data sets. Furthermore, ADC values were compared using a Wilcoxon test. A p-value <0.05 indicated statistically significant differences.

Results

There were no statistically significant differences regarding SNR pre-contrast (mean: 48.1), after gadobutrol (mean: 47.7) or after EOB-Gadolinium-DTPA (mean: 50.0; values for b = 50 s/mm²). Similarly, no significant differences were found for CNR (average values:34.4 vs. 32.3 vs. 30.7; b = 50 s/mm²) nor for ADC-values (mean: 1.5 vs. 1.4 vs. 1.5 × 10⁻³ mm²/s) of HCC.

Conclusion

There is no significant difference regarding DWI in patients with cirrhosis before and after contrast injection. Hence, it is reliable to run DWI after gadolinium either as an alternative for unsuccessful pre-contrast DWI or as a gap filler to spare time in EOB-Gadolinium-DTPA imaging.     

Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions

Aim

The aim of this study is to evaluate the value of the apparent diffusion coefficient (ADC) obtained in diffusion-weighted (DW) MR sequences for the differentiation between malignant and benign bone marrow lesions.

Method

Forty-five patients with altered signal intensity vertebral bodies on conventional MR sequences were included. The cause of altered signal intensity was benign osteoporotic collapse in 16, acute neoplastic infiltration in 15, and infectious processes in 14; based on plain-film, CT, bone scintigraphy, conventional MR studies, biopsy or follow-up. All patients underwent isotropic DW MR images (multi-shot EPI, b values of 0 and 500 s/mm²). Signal intensity at DW MR images was evaluated and ADC values were calculated and compared between malignancy, benign edema and infectious spondylitis.

Results

Acute malignant fractures were hyperintense compared to normal vertebral bodies on the diffusion-weighted sequence, except in one patient with sclerotic metastases. Mean ADC value from benign edema (1.9 ± 0.39 × 10⁻³ mm²/s) was significantly (p < 0.0001) higher than untreated metastasic lesions (0.9 ± 1.3 × 10⁻³ mm²/s). Mean ADC value of infectious spondilytis (0.96 ± 0.49 × 10⁻³ mm²/s) was not statistically (p > 0.05) different from untreated metastasic lesions. ADC value was low (0.75 × 10⁻³ mm²/s) in one case of subacute benign fracture.

Conclusions

ADC values are a useful complementary tool to characterize bone marrow lesions, in order to distinguish acute benign fractures from malignant or infectious bone lesions. However, ADC values are not valuable in order to differentiate malignancy from infection.